These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1533735)

  • 1. The acute effect of smoking on platelet and endothelial release reaction is suppressed in chronic smokers.
    Ozdemir O; Karaaslan Y; Ozcebe O; Dündar S; Kirazli S
    Thromb Res; 1992 Jan; 65(2):263-74. PubMed ID: 1533735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of chronic smoking on the fibrinolytic potential of plasma and platelets.
    Simpson AJ; Gray RS; Moore NR; Booth NA
    Br J Haematol; 1997 Apr; 97(1):208-13. PubMed ID: 9136967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the release of a plasminogen activator inhibitor by human platelets.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Apr; 55(2):201-5. PubMed ID: 2940723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in plasma tissue plasminogen activator, plasminogen activator inhibitor-1 and beta-thromboglobulin content in ischemic stroke.
    Zhuang P; Wo D; Xu ZG; Wei W; Mao HM
    J Clin Neurosci; 2015 Jul; 22(7):1123-7. PubMed ID: 26002716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen levels of plasminogen activator inhibitor type 1 in citrated plasma: determination of the contribution of platelets.
    Grimaudo V; Bachmann F; Kruithof EK
    Haemostasis; 1990; 20(6):329-33. PubMed ID: 2151572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
    Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
    J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsia.
    Koh SC; Anandakumar C; Montan S; Ratnam SS
    Gynecol Obstet Invest; 1993; 35(4):214-21. PubMed ID: 8330765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking increases thromboxane A2 formation without affecting platelet survival in young healthy females.
    Dotevall A; Rångemark C; Eriksson E; Kutti J; Wadenvik H; Wennmalm A
    Thromb Haemost; 1992 Nov; 68(5):583-8. PubMed ID: 1455405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of local tissue-type plasminogen activator release by endothelium-dependent and endothelium-independent agonists in human vasculature.
    Stein CM; Brown N; Vaughan DE; Lang CC; Wood AJ
    J Am Coll Cardiol; 1998 Jul; 32(1):117-22. PubMed ID: 9669258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia.
    Gilabert J; Estellés A; Aznar J; España F; Andrés C; Santos T; Vallés J
    Thromb Haemost; 1990 Jun; 63(3):361-6. PubMed ID: 2144918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking is associated with altered endothelial-derived fibrinolytic and antithrombotic factors: an in vitro demonstration.
    Barua RS; Ambrose JA; Saha DC; Eales-Reynolds LJ
    Circulation; 2002 Aug; 106(8):905-8. PubMed ID: 12186791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of venous occlusion on the PAI and antiplasmins release from platelets.
    Woods AI; Nadra CA; Lazzari MA
    Thromb Res; 1989 Nov; 56(3):491-5. PubMed ID: 2515615
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms contributing to increased synthesis of plasminogen activator inhibitor type 1 in endothelial cells by constituents of platelets and their implications for thrombolysis.
    Fujii S; Hopkins WE; Sobel BE
    Circulation; 1991 Feb; 83(2):645-51. PubMed ID: 1991382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of plasminogen activator inhibitor by products released from platelets.
    Fujii S; Sobel BE
    Circulation; 1990 Oct; 82(4):1485-93. PubMed ID: 2401077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator system in smokers and non-smokers with and without periodontal disease.
    Buduneli N; Buduneli E; Kardeşler L; Lappin D; Kinane DF
    J Clin Periodontol; 2005 Apr; 32(4):417-24. PubMed ID: 15811061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between smoking and fibrinolytic system with special reference to t-PA and PA inhibitor.
    Hashimoto Y; Kobayashi A; Yamazaki N; Takada Y; Takada A
    Thromb Res; 1988 Aug; 51(3):303-11. PubMed ID: 3140409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette Smoking-Associated Alterations in Serotonin/Adrenalin Signaling Pathways of Platelets.
    Lowery CL; Elliott C; Cooper A; Hadden C; Sonon RN; Azadi P; Williams DK; Marsh JD; Woulfe DS; Kilic F
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28522678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of third-generation beta-blocker antihypertensive treatment on endothelial function and the prothrombotic state: effects of smoking.
    Vyssoulis GP; Marinakis AG; Aznaouridis KA; Karpanou EA; Arapogianni AN; Cokkinos DV; Stefanadis CI
    Am J Hypertens; 2004 Jul; 17(7):582-9. PubMed ID: 15233977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin generation as an acute effect of cigarette smoking.
    Kimura S; Nishinaga M; Ozawa T; Shimada K
    Am Heart J; 1994 Jul; 128(1):7-11. PubMed ID: 8017287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired capacity for acute endogenous fibrinolysis in smokers is restored by ascorbic acid.
    Kaehler J; Koeke K; Karstens M; Schneppenheim R; Meinertz T; Heitzer T
    Free Radic Biol Med; 2008 Feb; 44(3):315-21. PubMed ID: 18215739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.